A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Male

Summary

A study conducted on healthy volunteers to determine the safety, tolerability and affect on the human body by experimental drug GSK557296.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Diketopiperazines

Criteria

Inclusion Criteria:

• Healthy males who are 18 to 45 years of age

• Body mass index between 19 and 30 with a body weight greater than 110 pounds and deemed healthy by a physician

• Non-smokers

Exclusion Criteria:

• Alcohol consumption averaging more than 7 drinks per week

• Positive for Hepatitis C antibody, Hepatitis B antigen or HIV

• Any use of prescription drugs or non prescription drugs